BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31614146)

  • 1. Beyond its antioxidant properties: Quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats.
    Salama YA; El-Karef A; El Gayyar AM; Abdel-Rahman N
    Life Sci; 2019 Nov; 236():116933. PubMed ID: 31614146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways.
    Zeyada MS; Abdel-Rahman N; El-Karef A; Yahia S; El-Sherbiny IM; Eissa LA
    Life Sci; 2020 Nov; 261():118458. PubMed ID: 32961231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells.
    Zhang S; Yang Y; Liang Z; Duan W; Yang J; Yan J; Wang N; Feng W; Ding M; Nie Y; Jin Z
    PLoS One; 2013; 8(12):e83699. PubMed ID: 24386256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saxagliptin defers thioacetamide-induced hepatocarcinogenesis in rats: A novel suppressive impact on Wnt/Hedgehog/Notch1 signaling.
    Abd Elhameed AG; Helal MG; Said E; Salem HA
    Environ Toxicol Pharmacol; 2021 Aug; 86():103668. PubMed ID: 33945853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement.
    Mohamed AA; Zaghloul RA; Abdelghany AM; El Gayar AM
    J Biochem Mol Toxicol; 2022 Apr; 36(4):e22989. PubMed ID: 35179263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma.
    Kunnimalaiyaan S; Sokolowski KM; Balamurugan M; Gamblin TC; Kunnimalaiyaan M
    PLoS One; 2015; 10(5):e0127464. PubMed ID: 26011160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
    Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
    Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Chemopreventive Role of Boldine Against Hepatocellular Carcinoma via Modulation of Cell Cycle Proteins in Rat Model.
    Subramaniam N; Kannan P; Sundaram J; Mari A; Velli SK; Salam S; Krishnan P; Balaraman G; Thiruvengadam D
    Anticancer Agents Med Chem; 2021; 21(18):2546-2552. PubMed ID: 33535961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.
    Sharma A; Bhat MK
    Integr Cancer Ther; 2011 Dec; 10(4):NP4-14. PubMed ID: 21994207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways.
    Elmansi AM; El-Karef AA; Shishtawy MMEl; Eissa LA
    Ann Hepatol; 2017; 16(4):607-618. PubMed ID: 28611265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways.
    Abd-Elbaset M; Mansour AM; Ahmed OM; Abo-Youssef AM
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1611-1624. PubMed ID: 32270258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
    Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
    Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells.
    Im E; Yeo C; Lee EO
    Life Sci; 2018 Sep; 209():259-266. PubMed ID: 30107166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
    Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS
    J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting p53/TRAIL/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats.
    Nazmy EA; El-Khouly OA; Zaki MMA; Elsherbiny NM; Said E; Al-Gayyar MMH; Salem HA
    Environ Toxicol Pharmacol; 2019 Nov; 72():103240. PubMed ID: 31421311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic potential of CK2α and its regulatory role in EGF-induced HDAC2 expression in human liver cancer.
    Kim HS; Chang YG; Bae HJ; Eun JW; Shen Q; Park SJ; Shin WC; Lee EK; Park S; Ahn YM; Park WS; Lee JY; Nam SW
    FEBS J; 2014 Feb; 281(3):851-61. PubMed ID: 24616922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
    Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
    Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.